2/11
06:32 am
gmab
Is Genmab (CPSE:GMAB) Attractively Priced After Recent Share Price Pullback? [Yahoo! Finance]
Low
Report
Is Genmab (CPSE:GMAB) Attractively Priced After Recent Share Price Pullback? [Yahoo! Finance]
1/30
02:18 am
gmab
EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB) [Yahoo! Finance]
Low
Report
EPKINLY Trial Results Prompt Price Target Cut for Genmab (GMAB) [Yahoo! Finance]
1/29
04:27 pm
gmab
Grant of Restricted Stock Units and Warrants to Employees in Genmab [Yahoo! Finance]
Low
Report
Grant of Restricted Stock Units and Warrants to Employees in Genmab [Yahoo! Finance]
1/28
08:46 am
gmab
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $39.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $39.00 price target on the stock.
1/24
07:11 pm
gmab
Genmab (CPSE:GMAB) Valuation Check After Epcoritamab Trial Update And DARZALEX Royalty Momentum [Yahoo! Finance]
Low
Report
Genmab (CPSE:GMAB) Valuation Check After Epcoritamab Trial Update And DARZALEX Royalty Momentum [Yahoo! Finance]
1/23
10:06 am
gmab
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight [Seeking Alpha]
Low
Report
Genmab: Darzalex Growth Fuels Rally, Upside Is Tight [Seeking Alpha]
1/22
12:28 am
gmab
Genmab (GMAB)'s Future Potential Underappreciated by Market [Yahoo! Finance]
Low
Report
Genmab (GMAB)'s Future Potential Underappreciated by Market [Yahoo! Finance]
1/21
06:23 am
gmab
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
Medium
Report
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
1/20
08:03 am
gmab
Genmab A/S (NASDAQ:GMAB) had its price target lowered by analysts at HC Wainwright from $41.00 to $39.00. They now have a "buy" rating on the stock.
Low
Report
Genmab A/S (NASDAQ:GMAB) had its price target lowered by analysts at HC Wainwright from $41.00 to $39.00. They now have a "buy" rating on the stock.
1/20
05:27 am
gmab
Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside [Yahoo! Finance]
Low
Report
Genmab A/S (GMAB) Shares Gain Analyst Support as Deutsche Bank Sees Oncology Upside [Yahoo! Finance]
1/16
01:51 pm
gmab
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Yahoo! Finance]
Low
Report
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Yahoo! Finance]
1/16
01:31 pm
gmab
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Medium
Report
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
1/16
01:30 pm
gmab
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Medium
Report
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
1/16
12:32 am
gmab
Is Genmab (CPSE:GMAB) Pricing Reflect Its Recent Biotech Momentum And DCF Upside Potential [Yahoo! Finance]
Medium
Report
Is Genmab (CPSE:GMAB) Pricing Reflect Its Recent Biotech Momentum And DCF Upside Potential [Yahoo! Finance]
1/15
02:36 pm
gmab
Genmab A/S (GMAB): A Bull Case Theory [Yahoo! Finance]
Low
Report
Genmab A/S (GMAB): A Bull Case Theory [Yahoo! Finance]
1/11
05:01 pm
gmab
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records [Fortune]
Low
Report
Anthropic unveils Claude for Healthcare, expands life science features, and partners with HealthEx to let users connect medical records [Fortune]
1/10
05:26 am
gmab
Genmab: AI Partnership And Clinical Data Fuel Growth [Seeking Alpha]
Low
Report
Genmab: AI Partnership And Clinical Data Fuel Growth [Seeking Alpha]
1/7
09:18 am
gmab
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence [Yahoo! Finance]
Low
Report
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence [Yahoo! Finance]
1/7
09:00 am
gmab
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
Low
Report
Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic Artificial Intelligence
1/5
03:24 am
gmab
Assessing Genmab (CPSE:GMAB) Valuation As Share Price Momentum Shows Signs Of Cooling [Yahoo! Finance]
Low
Report
Assessing Genmab (CPSE:GMAB) Valuation As Share Price Momentum Shows Signs Of Cooling [Yahoo! Finance]
12/31
08:48 am
gmab
Here's Why Genmab A/S (GMAB) Rose in Q3 [Yahoo! Finance]
Low
Report
Here's Why Genmab A/S (GMAB) Rose in Q3 [Yahoo! Finance]
12/30
09:12 am
gmab
Genmab shelves Phase III lung cancer candidate [Yahoo! Finance]
Low
Report
Genmab shelves Phase III lung cancer candidate [Yahoo! Finance]
12/29
09:16 am
gmab
Genmab scraps development of experimental cancer therapy [Yahoo! Finance]
Low
Report
Genmab scraps development of experimental cancer therapy [Yahoo! Finance]
12/29
08:23 am
gmab
Genmab Portfolio Prioritization Update [Yahoo! Finance]
Low
Report
Genmab Portfolio Prioritization Update [Yahoo! Finance]
12/29
08:12 am
gmab
Genmab Portfolio Prioritization Update
Low
Report
Genmab Portfolio Prioritization Update